Matches in SemOpenAlex for { <https://semopenalex.org/work/W3047822352> ?p ?o ?g. }
- W3047822352 endingPage "S117" @default.
- W3047822352 startingPage "S110" @default.
- W3047822352 abstract "Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies globally. We have previously explored the clinical efficacy of intraperitoneal (IP) paclitaxel therapy for patients with PDAC and peritoneal metastasis, which demonstrated favourable response and disease control rates. However, the real implications of conversion surgery after IP therapy remain unclear.We conducted two multicenter clinical trials of IP therapy with paclitaxel in patients with PDAC and peritoneal metastasis. We focused on patients who underwent conversion surgery and investigated the long-term outcomes, particularly, initial recurrence patterns and long-term survival.Seventy-nine patients with PDAC and peritoneal metastasis were treated, and 33 (41.8%) patients received SP (intravenous IP paclitaxel with S-1) and 46 (58.3%) were administered GAP (intravenous gemcitabine + nab-paclitaxel combined with IP paclitaxel) combination therapy. Of the 79 patients, 16 (20.3%) underwent conversion surgery. The median time to surgery was 9.0 (range, 4.1-13.0) months after the initiation of chemotherapy. Finally, 13 (81.3%) patients underwent R0 resection. Evans grade was IIA in nine patients, IIB in four patients, III in two patients, and IV in one patient. The median overall survival time in patients who underwent conversion surgery was 32.5 (range, 13.5-66.9) months. Twelve (75.0%) patients were found to have experienced recurrence after conversion surgery. Especially, peritoneal recurrence was observed in 50% of patients as the initial recurrence pattern. The median recurrence-free survival time was 9.2 (range, 5.1-32.8) months, and three patients have survived without recurrence to date.Our IP therapy displays promising clinical efficacy with acceptable tolerability in patients with PDAC and peritoneal metastasis. Although we could observe some super-responders in the cohort, further improvements in IP therapy are warranted." @default.
- W3047822352 created "2020-08-13" @default.
- W3047822352 creator A5014926431 @default.
- W3047822352 creator A5017952316 @default.
- W3047822352 creator A5018146056 @default.
- W3047822352 creator A5020304167 @default.
- W3047822352 creator A5022391772 @default.
- W3047822352 creator A5029053797 @default.
- W3047822352 creator A5033152224 @default.
- W3047822352 creator A5039507236 @default.
- W3047822352 creator A5040347472 @default.
- W3047822352 creator A5040731065 @default.
- W3047822352 creator A5043799958 @default.
- W3047822352 creator A5045459990 @default.
- W3047822352 creator A5047606517 @default.
- W3047822352 creator A5052392647 @default.
- W3047822352 creator A5070551493 @default.
- W3047822352 creator A5075713045 @default.
- W3047822352 creator A5076319004 @default.
- W3047822352 creator A5086122888 @default.
- W3047822352 creator A5087998978 @default.
- W3047822352 creator A5090915905 @default.
- W3047822352 date "2021-04-01" @default.
- W3047822352 modified "2023-10-07" @default.
- W3047822352 title "Conversion surgery in patients with pancreatic cancer and peritoneal metastasis" @default.
- W3047822352 cites W1578654420 @default.
- W3047822352 cites W1944392621 @default.
- W3047822352 cites W1955000909 @default.
- W3047822352 cites W1964089649 @default.
- W3047822352 cites W2018195451 @default.
- W3047822352 cites W2022501291 @default.
- W3047822352 cites W2036876326 @default.
- W3047822352 cites W2061174719 @default.
- W3047822352 cites W2072341496 @default.
- W3047822352 cites W2073667430 @default.
- W3047822352 cites W2089464452 @default.
- W3047822352 cites W2122498485 @default.
- W3047822352 cites W2130409622 @default.
- W3047822352 cites W2133778309 @default.
- W3047822352 cites W2153682404 @default.
- W3047822352 cites W2154175915 @default.
- W3047822352 cites W2284998650 @default.
- W3047822352 cites W2298579443 @default.
- W3047822352 cites W2345822778 @default.
- W3047822352 cites W2346921980 @default.
- W3047822352 cites W2514265185 @default.
- W3047822352 cites W2615690404 @default.
- W3047822352 cites W2801279586 @default.
- W3047822352 cites W2801301689 @default.
- W3047822352 cites W2963742674 @default.
- W3047822352 cites W2982461141 @default.
- W3047822352 cites W3040038295 @default.
- W3047822352 doi "https://doi.org/10.21037/jgo-20-243" @default.
- W3047822352 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8100706" @default.
- W3047822352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33968431" @default.
- W3047822352 hasPublicationYear "2021" @default.
- W3047822352 type Work @default.
- W3047822352 sameAs 3047822352 @default.
- W3047822352 citedByCount "10" @default.
- W3047822352 countsByYear W30478223522021 @default.
- W3047822352 countsByYear W30478223522022 @default.
- W3047822352 countsByYear W30478223522023 @default.
- W3047822352 crossrefType "journal-article" @default.
- W3047822352 hasAuthorship W3047822352A5014926431 @default.
- W3047822352 hasAuthorship W3047822352A5017952316 @default.
- W3047822352 hasAuthorship W3047822352A5018146056 @default.
- W3047822352 hasAuthorship W3047822352A5020304167 @default.
- W3047822352 hasAuthorship W3047822352A5022391772 @default.
- W3047822352 hasAuthorship W3047822352A5029053797 @default.
- W3047822352 hasAuthorship W3047822352A5033152224 @default.
- W3047822352 hasAuthorship W3047822352A5039507236 @default.
- W3047822352 hasAuthorship W3047822352A5040347472 @default.
- W3047822352 hasAuthorship W3047822352A5040731065 @default.
- W3047822352 hasAuthorship W3047822352A5043799958 @default.
- W3047822352 hasAuthorship W3047822352A5045459990 @default.
- W3047822352 hasAuthorship W3047822352A5047606517 @default.
- W3047822352 hasAuthorship W3047822352A5052392647 @default.
- W3047822352 hasAuthorship W3047822352A5070551493 @default.
- W3047822352 hasAuthorship W3047822352A5075713045 @default.
- W3047822352 hasAuthorship W3047822352A5076319004 @default.
- W3047822352 hasAuthorship W3047822352A5086122888 @default.
- W3047822352 hasAuthorship W3047822352A5087998978 @default.
- W3047822352 hasAuthorship W3047822352A5090915905 @default.
- W3047822352 hasBestOaLocation W30478223521 @default.
- W3047822352 hasConcept C121608353 @default.
- W3047822352 hasConcept C126322002 @default.
- W3047822352 hasConcept C141071460 @default.
- W3047822352 hasConcept C143998085 @default.
- W3047822352 hasConcept C2776694085 @default.
- W3047822352 hasConcept C2777292972 @default.
- W3047822352 hasConcept C2779013556 @default.
- W3047822352 hasConcept C2780210213 @default.
- W3047822352 hasConcept C2780258809 @default.
- W3047822352 hasConcept C71924100 @default.
- W3047822352 hasConcept C90924648 @default.
- W3047822352 hasConceptScore W3047822352C121608353 @default.
- W3047822352 hasConceptScore W3047822352C126322002 @default.
- W3047822352 hasConceptScore W3047822352C141071460 @default.